129 related articles for article (PubMed ID: 12906339)
1. Evaluation of monolithic osmotic tablet system for nifedipine delivery in vitro and in vivo.
Liu X; Chen D; Zhang R
Drug Dev Ind Pharm; 2003 Aug; 29(7):813-9. PubMed ID: 12906339
[TBL] [Abstract][Full Text] [Related]
2. Development of monolithic osmotic pump tablet system for isosorbide-5-mononitrate delivery and evaluation of it in vitro and in vivo.
Duan X; Liu Q; Zhang Y; Bi K; Chen X; Wang Y; Luo G
Drug Dev Ind Pharm; 2009 Apr; 35(4):499-507. PubMed ID: 18979308
[TBL] [Abstract][Full Text] [Related]
3. Monolithic osmotic tablet system for nifedipine delivery.
Liu L; Khang G; Rhee JM; Lee HB
J Control Release; 2000 Jul; 67(2-3):309-22. PubMed ID: 10825563
[TBL] [Abstract][Full Text] [Related]
4. [Sandwiched osmotic pump tablet for controlled release of water-insoluble drug].
Liu LX; Khang G; Rhee JM; Lee HB
Yao Xue Xue Bao; 2003 Aug; 38(8):620-3. PubMed ID: 14628456
[TBL] [Abstract][Full Text] [Related]
5. A squeeze-type osmotic tablet for controlled delivery of nifedipine.
Park JS; Shin JH; Lee DH; Kim MS; Rhee JM; Lee HB; Khang G
J Biomater Sci Polym Ed; 2008; 19(1):31-45. PubMed ID: 18177552
[TBL] [Abstract][Full Text] [Related]
6. The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast.
Schug BS; Brendel E; Chantraine E; Wolf D; Martin W; Schall R; Blume HH
Br J Clin Pharmacol; 2002 Jun; 53(6):582-8. PubMed ID: 12047482
[TBL] [Abstract][Full Text] [Related]
7. [Unitary-core osmotic pump tablet for controlled release of water-insoluble drug].
Liu LX; Xu Q; Khang G; Rhee JM; Lee HB
Yao Xue Xue Bao; 2003 Dec; 38(12):966-7. PubMed ID: 15040097
[TBL] [Abstract][Full Text] [Related]
8. Preparation of monolithic osmotic pump system by coating the indented core tablet.
Liu L; Che B
Eur J Pharm Biopharm; 2006 Oct; 64(2):180-4. PubMed ID: 16797951
[TBL] [Abstract][Full Text] [Related]
9. Monolithic osmotic tablet containing solid dispersion of 10-hydroxycamptothecin.
Chen H; Jiang G; Ding F
Drug Dev Ind Pharm; 2009 Feb; 35(2):131-7. PubMed ID: 19169941
[TBL] [Abstract][Full Text] [Related]
10. A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic, suspending and expanding agent.
Lu EX; Jiang ZQ; Zhang QZ; Jiang XG
J Control Release; 2003 Oct; 92(3):375-82. PubMed ID: 14568418
[TBL] [Abstract][Full Text] [Related]
11. Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union.
Wonnemann M; Schug B; Schmücker K; Brendel E; van Zwieten PA; Blume H
Int J Clin Pharmacol Ther; 2006 Jan; 44(1):38-48. PubMed ID: 16425970
[TBL] [Abstract][Full Text] [Related]
12. The kinetics of nifedipine release from porous hydrophilic matrices and the pharmacokinetics in man.
Leucuta SE
Pharmazie; 1988 Dec; 43(12):845-8. PubMed ID: 3247376
[TBL] [Abstract][Full Text] [Related]
13. Sandwiched osmotic tablet core for nifedipine controlled delivery.
Liu L; Khang G; Rhee JM; Lee HB
Biomed Mater Eng; 1999; 9(5-6):297-310. PubMed ID: 10822485
[TBL] [Abstract][Full Text] [Related]
14. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
Anschütz M; Wonnemann M; Schug B; Toal C; Donath F; Pontius A; Pauli K; Brendel E; Blume H
Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768
[TBL] [Abstract][Full Text] [Related]
15. Relative bioavailability of four controlled-release nifedipine products.
Schall R; Müller FO; Hundt HK; Duursema L; Groenewoud G; Van Dyk M; Van Schalkwyk AM
Biopharm Drug Dispos; 1994 Aug; 15(6):493-503. PubMed ID: 7993987
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting the release of nifedipine from a swellable elementary osmotic pump.
Nokhodchi A; Momin MN; Shokri J; Shahsavari M; Rashidi PA
Drug Deliv; 2008 Jan; 15(1):43-8. PubMed ID: 18197523
[TBL] [Abstract][Full Text] [Related]
17. Time-release compression-coated core tablet containing nifedipine for chronopharmacotherapy.
Sawada T; Kondo H; Nakashima H; Sako K; Hayashi M
Int J Pharm; 2004 Aug; 280(1-2):103-11. PubMed ID: 15265551
[TBL] [Abstract][Full Text] [Related]
18. Nifedipine controlled delivery by sandwiched osmotic tablet system.
Liu L; Ku J; Khang G; Lee B; Rhee JM; Lee HB
J Control Release; 2000 Aug; 68(2):145-56. PubMed ID: 10925123
[TBL] [Abstract][Full Text] [Related]
19. Effects of Dissolution Medium pH and Simulated Gastrointestinal Contraction on Drug Release From Nifedipine Extended-Release Tablets.
Gao Z; Ngo C; Ye W; Rodriguez JD; Keire D; Sun D; Wen H; Jiang W
J Pharm Sci; 2019 Mar; 108(3):1189-1194. PubMed ID: 30343136
[TBL] [Abstract][Full Text] [Related]
20. Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet.
Liu L; Xu X
Int J Pharm; 2008 Mar; 352(1-2):225-30. PubMed ID: 18068918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
